Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 416 followers
Latest posts
Last updated about 12 hours ago
ESC: AZ, Ionis' Wainua post-mortem throws water on silencer-plus-stabilizer approach in ATTR-CM
about 12 hours ago
After a surprise washout in a recent phase 3 trial of AstraZeneca...
Takeda bolsters blood cancer portfolio with FDA nod for Mimrylo in polycythemia vera
1 day ago
The FDA has approved Takeda’s Mimrylo (rusfertide) for polycythemia vera, introducing a...
The Clinician With 2 Million Followers Is Shaping Prescribing Behavior. Pharma Can Now Be Part of That Conversation
1 day ago
Millions of HCPs follow digital opinion leaders online. Here's how pharma can...
Why real-world data is becoming a strategic asset in drug development
1 day ago
Labcorp's Catie Schlechter discusses how sponsors are using real-world data to improve...
Lilly scores Novo-pressuring Mounjaro expansion to curb heart risks in diabetes patients
1 day ago
In their high-profile competition in the diabetes and obesity markets, Eli Lilly...
MrBeast, Snapchat, AI and more: Pharma marketing’s pulse check
1 day ago
In this week’s episode of “The Top Line,” Fierce’s Ben Adams and...
Teva saddles up as stalking horse bidder for bankrupt BioXcel’s neuroscience portfolio
1 day ago
BioXcel Therapeutics has filed for bankruptcy and lined up a deal for...
Stephen Farquhar takes over as CEO of Publicis Health Media
1 day ago
Stephen Farquhar has taken over as CEO of Publicis Health Media (PHM)...
Biogen enlists lupus patient advocate to share social media story of resilience
1 day ago
Biogen highlighted patient advocate and content creator Naomi Rose’s story living with...
Fierce Pharma Asia—Roche’s $2.5B obesity deal; Akeso CEO’s defense; Lawmaker’s reflection on China
1 day ago
Roche is taking a less-trodden path in obesity. Akeso CEO counters concerns...
ESC: Cytokinetics delves deeper on ‘huge’ Myqorzo readout, fueling cardiomyopathy expansion bid
2 days ago
Cytokinetics' cardiac myosin inhibitor, Myqorzo, is the first to demonstrate significant, clinically...
Omnicom PR consultancy injects new leadership into pharma push
2 days ago
Omnicom’s maslansky + partners has expanded its leadership team, hiring two new...